Botanical species · safety record

Epilobium parviflorum

The EFSA Compendium of Botanicals holds 2 constituent measurements and 1 adverse-effect record for Epilobium parviflorum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Epilobium parviflorum Schreb.

2Constituent measurements

1Safety records

2Cited sources

13Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 13 licensed products naming Epilobium parviflorum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Aerial parts
Flower
Herb
Herb top

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Tannins	Leaves	Solvent extraction	18.2 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Tannins	Flower	Solvent extraction	32.3 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive: pancreas	Aerial part of plants	Solvent extraction	Pig (as animal)	In vitro	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Slanc, Petra., Doljak, Bojan., Kreft, Samo., Lunder, Mojca., Janes, Damjan., Strukelj, Borut. Screening of selected food and medicinal plant extracts for pancreatic lipase inhibition. Phytotherapy Research, 2009, p. 874-877.
Remmel, Indrek., Vares, Lauri., Toom, Lauri., Matto, Vallo., Raal, Ain. Phenolic Compounds in Five Epilobium Species Collected from Estonia. Natural product communications, 2012, vol. 7, no. 10, p. 1323-1324.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature